Takeda's breakthrough in dengue's tetravalent challenge offers a crucial lesson for Indian pharma

Takeda's breakthrough in dengue's tetravalent challenge offers a crucial lesson for Indian pharma. Achieving durable, multi-strain protection requires deep scientific R&D and a long-term view, not just speed. For India, this vaccine could redefine public health strategy against an endemic threat. https://pharma.economictimes.indiatimes.com/news/pharma-industry/tackling-dengues-four-serotype-challenge-inside-takedas-science-behind-durable-immunity/127686761